Linked Data API

Show Search Form

Search Results

967474
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prescription Drugs: Misuse more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have to secure funding for existing prescribed medicines withdrawal centres. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL9967 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-17more like thismore than 2018-09-17
star this property answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL9968 more like this
HL9969 more like this
HL9971 more like this
star this property question first answered
less than 2018-09-17T14:06:06.01Zmore like thismore than 2018-09-17T14:06:06.01Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
2024
unstar this property label Biography information for Lord Hunt of Kings Heath more like this
967475
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prescription Drugs: Misuse more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what plans they have, if any, to increase the number of prescribed medicines withdrawal centres to cover the whole of England. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL9968 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-17more like thismore than 2018-09-17
star this property answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL9967 more like this
HL9969 more like this
HL9971 more like this
star this property question first answered
less than 2018-09-17T14:06:06.08Zmore like thismore than 2018-09-17T14:06:06.08Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
2024
unstar this property label Biography information for Lord Hunt of Kings Heath more like this
967476
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Prescription Drugs: Misuse more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether they will ensure that in establishing a 24 hour helpline for people affected by prescribed medicines addiction they will also ensure that adequate services are in place to refer patients to. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL9969 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-17more like thismore than 2018-09-17
star this property answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL9967 more like this
HL9968 more like this
HL9971 more like this
star this property question first answered
less than 2018-09-17T14:06:06.143Zmore like thismore than 2018-09-17T14:06:06.143Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
2024
unstar this property label Biography information for Lord Hunt of Kings Heath more like this
967478
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Benzodiazepines: Misuse more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether they will establish a public inquiry into the harmful effects of prescribed benzodiazepine drug dependence over the last 50 years. more like this
star this property tabling member printed
Lord Hunt of Kings Heath more like this
star this property uin HL9971 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-17more like thismore than 2018-09-17
star this property answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN
HL9967 more like this
HL9968 more like this
HL9969 more like this
star this property question first answered
less than 2018-09-17T14:06:06.203Zmore like thismore than 2018-09-17T14:06:06.203Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
2024
unstar this property label Biography information for Lord Hunt of Kings Heath more like this
967470
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Health Visitors more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what training health visitors receive to enable them to identify incipient and actual cases of ante-natal depression, post-natal depression, and other maternal mental health issues. more like this
star this property tabling member printed
Baroness Hodgson of Abinger more like this
star this property uin HL9964 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-17more like thismore than 2018-09-17
star this property answer text <p>Health visitors are part of the nursing profession and regulated by the Nursing and Midwifery Council (NMC). Health visitors are qualified and registered nurses or midwives who have undertaken an approved training programme in Specialist Community Public Health Nursing - Health Visiting.</p><p>The NMC has the general function of promoting high standards of education and coordinating all stages of education to ensure that health visitors are equipped with the knowledge, skills and attitudes essential for professional practice, including continuous professional development (CPD). The NMC set the standards of education and training for the nursing profession expected at undergraduate and postgraduate level and approve curricula set by individual higher education institutes. In so doing, they set out the knowledge, skills and behaviours that both postgraduate and undergraduate nurses must be able to demonstrate.</p><p>CPD is a term used to describe a number of different training and development activities which may be required for the purposes of professional practice in the National Health Service. The NMC requires 35 hours of CPD relevant to scope of practice in the three year period since registration was last renewed, or joining the register.</p><p>The NMC are in the process of rewriting their standards. For example, in the new pre-registration nursing standards the NMC specify that registrants must have proficiencies in identifying risk and vulnerability, in all settings and across the lifespan and would expect post-natal depression to be included in the curriculum.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL9965 more like this
star this property question first answered
less than 2018-09-17T13:50:13.717Zmore like thismore than 2018-09-17T13:50:13.717Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4301
unstar this property label Biography information for Baroness Hodgson of Abinger more like this
967472
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Health Visitors more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government what continuous professional development health visitors are required to undertake to enable them to identify incipient and actual cases of ante-natal depression, post-natal depression, and other maternal mental health issues. more like this
star this property tabling member printed
Baroness Hodgson of Abinger more like this
star this property uin HL9965 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-17more like thismore than 2018-09-17
star this property answer text <p>Health visitors are part of the nursing profession and regulated by the Nursing and Midwifery Council (NMC). Health visitors are qualified and registered nurses or midwives who have undertaken an approved training programme in Specialist Community Public Health Nursing - Health Visiting.</p><p>The NMC has the general function of promoting high standards of education and coordinating all stages of education to ensure that health visitors are equipped with the knowledge, skills and attitudes essential for professional practice, including continuous professional development (CPD). The NMC set the standards of education and training for the nursing profession expected at undergraduate and postgraduate level and approve curricula set by individual higher education institutes. In so doing, they set out the knowledge, skills and behaviours that both postgraduate and undergraduate nurses must be able to demonstrate.</p><p>CPD is a term used to describe a number of different training and development activities which may be required for the purposes of professional practice in the National Health Service. The NMC requires 35 hours of CPD relevant to scope of practice in the three year period since registration was last renewed, or joining the register.</p><p>The NMC are in the process of rewriting their standards. For example, in the new pre-registration nursing standards the NMC specify that registrants must have proficiencies in identifying risk and vulnerability, in all settings and across the lifespan and would expect post-natal depression to be included in the curriculum.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL9964 more like this
star this property question first answered
less than 2018-09-17T13:50:13.78Zmore like thismore than 2018-09-17T13:50:13.78Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4301
unstar this property label Biography information for Baroness Hodgson of Abinger more like this
386886
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Bone Marrow Disorders more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL995 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL996 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.197Zmore like thismore than 2015-07-14T15:34:29.197Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386887
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether there are currently any trials for systemic amyloidosis in humans being conducted by the National Institute of Health Research charities or the commercial sector. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.297Zmore like thismore than 2015-07-14T15:34:29.297Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386888
star this property registered interest false more like this
star this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government which of the four phase 2 or 3 clinical trials for systemic amyloidosis approved since 2004 are still ongoing; and whether any of the trials have produced sufficient positive outcomes to encourage commercial development. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL996 more like this
star this property question first answered
less than 2015-07-14T15:34:29.553Zmore like thismore than 2015-07-14T15:34:29.553Z
star this property answering member
127
unstar this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
967440
star this property registered interest false more like this
star this property date less than 2018-09-04more like thismore than 2018-09-04
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 remove filter
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Community Nurses more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether the number of district nurses in England in community service organisations, such as NHS Community Healthcare Trusts, has reduced since 2010; and, if so, what measures they are taking to address any problems caused by such a reduction. more like this
star this property tabling member printed
Baroness Cox more like this
star this property uin HL9937 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-09-18more like thismore than 2018-09-18
star this property answer text <p>Community health care services are a crucial part of the health and social care system that allows patients to be cared for at the right time in the right place.</p><p>NHS Digital data shows a reduction in the number of full time equivalent district nurses in England from 7,546 in September 2010 to 4,587 in May 2018. These include staff working in hospital trusts and clinical commissioning groups, but not staff working in primary care or in general practitioner surgeries, local authorities or other providers. The number of district nurses in independent healthcare providers increased by 273, from September 2010 to September 2017. As a result of changes made in 2009 to the ways in which community services are provided – i.e. from a range of different types of provider – this does not represent the full picture and there will be a number of district nurses providing National Health Service services in organisations that do not provide a return to the Electronic Staff Records.</p><p>The training of new district nurses is important in maintaining a workforce that can deliver the needs of the population in the community. Health Education England has commissioned and funded the District Nursing Specialist Practice Qualification at a steady state over the last six years. These are based upon the requirements that local providers have informed Health Education England. However, year on year these commissions are not fully taken up and therefore Health Education England is working to better understand the reasons this may be.</p><p>Health Education England is now exploring the capacity and capability required of our community workforce to best meet the future needs of the population. Health Education England is evaluating the skills and knowledge required within the wider community workforce including district nurses. This has involved extensive engagement across England to understand how best to meet to needs of the local population, as well as develop a role that has a more desirable career pathway for prospective healthcare professionals. The Government is also supporting incentives for postgraduates who go on to work in community nursing roles, including ‘golden hellos’.</p><p>Patient safety remains a key priority for the Department and in 2017 we restated our commitment to the NHS being the “safest healthcare system in the world”. The Care Quality Commission (CQC) assesses all registered providers that deliver regulated activities against the Fundamental Standards, below which the standard of care must not fall. Staffing is one of the Standards, and the CQC inspections check that sufficient numbers of suitably qualified, competent, skilled and experienced staff are deployed within service providers. To this effect we would expect providers to continue to ensure patient safety in the community.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL9938 more like this
star this property question first answered
less than 2018-09-18T11:36:58.973Zmore like thismore than 2018-09-18T11:36:58.973Z
star this property answering member
4545
unstar this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
3364
unstar this property label Biography information for Baroness Cox more like this